title: Combination therapy of 177Lu and 90Y Dotatate for treatment of neuroendocrine cancer.
authors.affiliation: aDepartment of Medical Physics, Royal United Hospital Bath NHS Trust, Bath Departments of bNuclear Medicine cMedical Oncology, The Christie NHS Foundation Trust, Manchester, UK.
authors.forename: Ceri E
authors.initials: CE
authors.lastname: Ashton
authors.forename: Stephen P
authors.initials: SP
authors.lastname: Jeans
authors.forename: Juan W
authors.initials: JW
authors.lastname: Valle
mesh_terms: D003131:Combined Modality Therapy; D006801:Humans; D018358:Neuroendocrine Tumors / Q000378:metabolism / Q000532:radiotherapy*; D015282:Octreotide / Q000031:analogs & derivatives* / Q000627:therapeutic use; D009942:Organometallic Compounds / Q000627:therapeutic use*; D018000:Receptors, Peptide / Q000378:metabolism
chemical_list: C539274:90Y-octreotate, DOTA(0)-Tyr(3)-Thr(8)-; D009942:Organometallic Compounds; D018000:Receptors, Peptide; C447941:lutetium Lu 177 dotatate; D015282:Octreotide